Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278)Valentina Guarneri, PierFranco Conte, Antonio Frassoldati et al.|Clinical Breast Cancer|2008Cited by 57
Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer’s dementiaViviana Brembati, Marcella Catania, Federico Angelo Cazzaniga et al.|Alzheimer s Research & Therapy|2026Cited by 1